The EFMC-ISMC 2018 will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology.

Head of Business Development for Europe, Dr Bodo Spori will be joined by Principal Research Lead, Dr Gary Newton and Senior Scientist, Dr Nelly Piton at the event.  Find them at the poster sessions and ask them about how Domainex can support your drug discovery programme.